Javascript must be enabled to continue!
Data from The Transcription Factor Evi-1 Is Overexpressed, Promotes Proliferation, and Is Prognostically Unfavorable in Infratentorial Ependymomas
View through CrossRef
<div>Abstract<p><b>Purpose:</b> Ependymomas are glial tumors of presumably radial glial origin that share morphologic similarities with ependymal cells. The molecular genetics of ependymomas of supratentorial, infratentorial, and spinal location is heterogeneous. We aimed at identifying pathways operative in the development of infratentorial ependymomas.</p><p><b>Experimental Design:</b> To do so, gene expression profiles of tumor cells laser microdissected from infratentorial ependymomas (<i>n</i> = 15) were compared with that of nonneoplastic ependymal cells laser microdissected from autopsy tissue (<i>n</i> = 7).</p><p><b>Results:</b> Among 31 genes significantly overexpressed (>5-fold) in ependymomas, transcription factor <i>EVI1</i> (ecotropic viral integration site 1) showed the highest overexpression (35-fold). Evi-1 protein expression could be confirmed in formalin-fixed, paraffin-embedded samples of 26 of 28 infratentorial ependymomas but only in 7 of 47 nonependymal glial tumors (<i>P</i> < 0.001). Furthermore, <i>MDS1/EVI1</i> fusion transcripts were detectable in 17 of 28 infratentorial ependymomas and significantly correlated with MGMT (O6-methylguanine-DNA-methyltransferase) promoter hypermethylation (<i>P</i> < 0.05). In primary infratentorial ependymoma cells, transfection with <i>EVI1</i>-specific siRNAs resulted in significant growth inhibition [48 hours: 87% ± 2% and 74% ± 10% as compared with control (mean ± SD; <i>P</i> < 0.001)]. The prognostic role of <i>EVI1</i> could further be validated in an independent cohort of 39 infratentorial and 26 supratentorial ependymomas on the basis of mRNA expression profiling. Although in supratentorial ependymomas <i>EVI1</i> expression status had no prognostic impact, in infratentorial ependymomas, high <i>EVI1</i> expression was associated with shorter overall survival and progression-free survival.</p><p><b>Conclusions:</b> To conclude, the transcription factor Evi-1 is overexpressed in infratentorial ependymomas, promotes proliferation of ependymal tumor cells, and is prognostically unfavorable. <i>Clin Cancer Res; 17(11); 3631–7. ©2011 AACR</i>.</p></div>
American Association for Cancer Research (AACR)
Title: Data from The Transcription Factor Evi-1 Is Overexpressed, Promotes Proliferation, and Is Prognostically Unfavorable in Infratentorial Ependymomas
Description:
<div>Abstract<p><b>Purpose:</b> Ependymomas are glial tumors of presumably radial glial origin that share morphologic similarities with ependymal cells.
The molecular genetics of ependymomas of supratentorial, infratentorial, and spinal location is heterogeneous.
We aimed at identifying pathways operative in the development of infratentorial ependymomas.
</p><p><b>Experimental Design:</b> To do so, gene expression profiles of tumor cells laser microdissected from infratentorial ependymomas (<i>n</i> = 15) were compared with that of nonneoplastic ependymal cells laser microdissected from autopsy tissue (<i>n</i> = 7).
</p><p><b>Results:</b> Among 31 genes significantly overexpressed (>5-fold) in ependymomas, transcription factor <i>EVI1</i> (ecotropic viral integration site 1) showed the highest overexpression (35-fold).
Evi-1 protein expression could be confirmed in formalin-fixed, paraffin-embedded samples of 26 of 28 infratentorial ependymomas but only in 7 of 47 nonependymal glial tumors (<i>P</i> < 0.
001).
Furthermore, <i>MDS1/EVI1</i> fusion transcripts were detectable in 17 of 28 infratentorial ependymomas and significantly correlated with MGMT (O6-methylguanine-DNA-methyltransferase) promoter hypermethylation (<i>P</i> < 0.
05).
In primary infratentorial ependymoma cells, transfection with <i>EVI1</i>-specific siRNAs resulted in significant growth inhibition [48 hours: 87% ± 2% and 74% ± 10% as compared with control (mean ± SD; <i>P</i> < 0.
001)].
The prognostic role of <i>EVI1</i> could further be validated in an independent cohort of 39 infratentorial and 26 supratentorial ependymomas on the basis of mRNA expression profiling.
Although in supratentorial ependymomas <i>EVI1</i> expression status had no prognostic impact, in infratentorial ependymomas, high <i>EVI1</i> expression was associated with shorter overall survival and progression-free survival.
</p><p><b>Conclusions:</b> To conclude, the transcription factor Evi-1 is overexpressed in infratentorial ependymomas, promotes proliferation of ependymal tumor cells, and is prognostically unfavorable.
<i>Clin Cancer Res; 17(11); 3631–7.
©2011 AACR</i>.
</p></div>.
Related Results
Apparent Diffusion Coefficient to Evaluate Adult Intracranial Ependymomas: Relationship to Ki‐67 Proliferation Index
Apparent Diffusion Coefficient to Evaluate Adult Intracranial Ependymomas: Relationship to Ki‐67 Proliferation Index
ABSTRACTBACKGROUND AND PURPOSEThere are important differences in the treatment and prognosis of adult intracranial low‐grade ependymomas (grade II) versus anaplastic ependymomas (g...
EVI and MDS/EVI are required for adult intestinal stem cell formation during postembryonic vertebrate development
EVI and MDS/EVI are required for adult intestinal stem cell formation during postembryonic vertebrate development
The gene ectopic viral integration site 1 (EVI) and its variant myelodysplastic syndrome 1 (MDS)/EVI encode zinc‐finger proteins that have been recognized as important oncogenes in...
Peroxiredoxins and their expression in ependymomas
Peroxiredoxins and their expression in ependymomas
AimsPeroxiredoxins I–VI (Prxs) have recently been shown to have a role in the tumorigenesis of astrocytic brain tumours. In some tumour types they are associated with Nrf2 (transcr...
Expression of cyclo‐oxygenase‐2 in ependymal tumors
Expression of cyclo‐oxygenase‐2 in ependymal tumors
Up‐regulation of cyclo‐oxygenase‐2 (COX‐2), a cytokine‐induced enzyme that metabolizes arachidonic acid into prostaglandins, has been described in some brain tumors, including astr...
Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients
Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients
Object
The aim of this paper was to define the clinical characteristics of spinal ependymomas associated with neurofibromatosis Type 2 (NF2).
Methods
The authors retrospectively r...
Is Whole Brain Radiotherapy Enough for Palliative Care of Patients with Infratentorial Brain Metastases from Lung or Breast Cancer?
Is Whole Brain Radiotherapy Enough for Palliative Care of Patients with Infratentorial Brain Metastases from Lung or Breast Cancer?
Abstract
Background: Brain metastases (BM) occur in almost one third of patients with solid tumors. The aim of the study was to compare the prognosis of patients treated wi...
Subependymomas
Subependymomas
Abstract
Background.—Subependymomas are uncommonly encountered ependymal tumors, which are important to distinguish from ordinary ependymomas because of their genera...
Nuances in the management of cerebellopontine angle ependymomas: illustrative case
Nuances in the management of cerebellopontine angle ependymomas: illustrative case
BACKGROUND
Ependymomas are one of the most common pediatric brain tumors. Cerebellopontine angle ependymomas (CPAEs) are a subset of ependymomas that pose uniqu...

